Medicines patent pool receives first licence for HIV drugs from major pharmaceutical company
Submitted by susan on Wed, 2011-07-13 09:30
Gilead Sciences has become the first pharmaceutical company to set up a licensing agreement with the recently-established Medicines Patent Pool (MPP), in a move aimed toward increasing access in developing countries to drugs that treat HIV and Hepatitis B. The landmark deal was announced yesterday, 12 July.
Main Topic:
Attachment(s):
Mark Content Private(Internal):
External URL:
Additional image::
Main Type:
Email Alert:
0
26
15
Publication Date:
13/07/2011